| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |